Zusammenfassung
Überlegungen zum Screening des Lungenkarzinoms werden motiviert durch die sehr schlechte Prognose des Tumors bei Diagnose aufgrund von Symptomen (<15% 5-Jahres-Überleben), die deutlich bessere Prognose asymptomatischer früher Stadien (bis 80% 5-Jahres-Überleben), die hohe Sensitivität der nativen Niedrigdosis-CT für kleine Tumoren und die gute Identifizierbarkeit von Risikopersonen.
Machbarkeitsstudien unter Verwendung genau definierter diagnostischer Algorithmen zum Umgang mit gefundenen Lungenrundherden zeigten einen großen Anteil (>50 bis >90%) kleiner, resektabler nichtkleinzelliger Lungenkarzinome in frühen Stadien mit guter Prognose der betroffenen Patienten bei einer geringen Rate unnötiger Biopsien. Da allerdings Verzerrungsfaktoren wie Überdiagnose, length-time und lead-time Aussagen zum tatsächlichen Nutzen der Methode hinsichtlich einer Senkung der Sterblichkeit am Lungenkarzinom nicht zulassen, werden derzeit die Ergebnisse großer prospektiver randomisierter Studien abgewartet.
Gleichzeitig sind andere Früherkennungsmethoden wie verfeinerte Sputumdiagnostik, Analyse molekularer Marker im Blut oder Atemluftanalyse in der Evaluation.
Abstract
Thoughts on screening for lung cancer are based on the very poor prognosis of this tumor when the diagnosis is made because of symptoms (<15% 5-year survival), the markedly better prognosis if it is detected in asymptomatic early stages (up to 80% 5-year survival), the high sensitivity of unenhanced low-dose CT in the detection of small tumors, and the clear definition of persons at risk.
Feasibility studies using well-defined diagnostic algorithms for management of detected pulmonary nodules have demonstrated a high proportion (>50 to >90%) of small, resectable non-small-cell lung carcinomas in the early stages, with a good prognosis for the patients affected and a low rate of unnecessary biopsies. However, biases such as overdiagnosis, length-time and lead-time could hamper potential reduction of mortality from lung cancer, and the results of large prospective randomized trials are therefore awaited.
At the same time, other techniques for early diagnosis of lung cancer are under evaluation, such as sophisticated methods of sputum analysis, molecular markers in the blood and analysis of exhaled air.
Literatur
American Cancer Society (1998) Cancer facts and figures. ACS, Atlanta, pp 1–36
Diederich S (2003) Screening for early lung cancer with low-dose spiral computed tomography. Lancet 362: 588–589
Diederich S, Lenzen H (2000) Radiation exposure associated with imaging of the chest: comparison of different radiographic and CT techniques. Cancer 89: 2457–2460
Diederich S, Thomas M, Semik M et al. (2004) Screening for early lung cancer with low-dose spiral computed tomography: results of annual follow-up examinations in asymptomatic smokers. Eur Radiol DOI 10.1007/s00330–003–220–5; Eur Radiol 2004 Jan 16 [Epub ahead of print] PMID: 14727146 [PubMed – as supplied by publisher]
Diederich S, Wormanns H, Heindel W (2001) Bronchialkarzinomscreening mit Niedrigdosis-CT: Aktueller Stand. Radiologe 41: 256–260
Diederich S, Wormanns H, Heindel W (2001) Radiologisches Screening des Bronchialkarzinoms: Aktueller Stand und zukünftige Perspektiven. Fortschr Röntgenstr 173: 873–882
Diederich S, Wormanns D, Heindel W (2002) Lungenkrebs-Früherkennung mit Low-dose CT: ein Update. Radiologe 42: 608–611
Diederich S, Wormanns D, Semik M et al. (2002) Screening for early lung cancer with low-dose spiral computed tomography: results of baseline examinations in 817 asymptomatic smokers. Radiology 222: 773–781
Eddy DM (1989) Screening for lung cancer. Ann Intern Med 111: 232–237
Fontana RS, Sanderson DR, Taylor WF et al. (1984) Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Mayo Clinic Study. Am Rev Respir Dis 130: 561–565
Frost JK, Ball WC, Levin M et al. (1984) Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins Study. Am Rev Respir Dis 130: 549–554
Hasegawa M, Sone S, Takashima S et al. (2000) Growth rate of small lung cancers detected on mass CT screening. Br J Radiol 73: 1252–1259
Henschke CI, McCauley DI, Yankelevitz DF et al. (1999) Early lung cancer action project. overall design and findings from baseline screening. Lancet 354: 99–105
Henschke CI, Naidich DP, Yankelevitz DF et al. (2001) Early lung cancer action project. Initial findings on repeat screenings. Cancer 92: 153–159
Henschke CI, Yankelevitz DF, Libby DM et al. for the International Early Lung Cancer Action Program Investigators (2006) Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 355: 1763–1771
Kaneko M, Eguchi K, Ohmatsu H et al. (1996) Peripheral lung cancer: screening and detection with low-dose spiral-CT versus radiography. Radiology 201: 798–802
Kubik A, Polak J (1986) Lung cancer detection: results of a randomized prospective study in Czechoslovakia. Cancer 57: 2428–2437
Machado RF, Laskowski D, Deffenderfer O et al. (2005) Detection of lung cancer by sensor array analyses of exhaled breath. Am J Respir Crit Care Med 17: 1286–1291
Melamed MR, Flehinger BJ, Zaman MB et al. (1984) Screening for early lung cancer. Results of the Memorial Sloan-Kettering Study in New York. Chest 86: 44–53
Mountain CF (1997) Revisions in the International System for Staging Lung Cancer. Chest 111: 1710–1717
Nawa T, Nakagawa T, Kusano S et al. (2002) Lung cancer screening using low-dose spiral CT. Chest 122: 15–20
Pastorino U, Bellomi M, Landoni C et al. (2003) Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results. Lancet 362: 593–597
Sobue T, Moriyama N, Kaneko M et al. (2002) Screening for lung cancer with low-dose helical computed tomography: anti-lung cancer association project. J Clin Oncol 20: 911–920
Sone S, Li F, Yang Z-G et al. (2001) Results of three-year mass screening programme for lung cancer using mobile low-dose spiral computed tomography scanner. Br J Cancer 84: 25–32
Sone S, Takashima S, Li F et al. (1998) Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet 351: 1242–1245
Swensen SJ, Jett JR, Hartman TE et al. (2003) Lung cancer screening with CT: Mayo Clinic Experience. Radiology 226: 756–761
Swensen SJ, Jett JR, Hartman TE et al. (2005) CT screening for lung cancer: five-year prospective experience. Radiology 235: 259–265
Swensen S, Jett JR, Slon JA et al. (2002) Screening for lung cancer with low-dose spiral computed tomography. Resp Crit Care Med 165: 508–513
Winer-Muram HT, Jennings SG, Tarver RD et al. (2002) Volumetric growth rate of stage I lung cancer prior to treatment: serial CT scanning. Radiology 223: 798–805
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Diederich, S. Screening des Lungenkarzinoms: Stand 2007. Radiologe 48, 39–44 (2008). https://doi.org/10.1007/s00117-007-1585-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00117-007-1585-6